Skip to main content

Table 1 Baseline data from 250 female and male overweight and obese participants

From: Relationships of low serum vitamin D3with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity

Parameter Evaluable N1 Mean(SD)
Age (y) 243 47.6(11.6)
Weight (kg) 243 97.3(18.2)
Height (cm) 243 166(8)
Body mass index (kg/m2) 243 35.4(5.2)
Body fat (%) 243 38.2(6.6)
2Waist (cm) 243 100.4(12.8)
2Systolic blood pressure (mmHg) 243 123(18)
2Diastolic blood pressure (mmHg) 243 70(10)
2Triglyceride (mmol/L) 243 1.56(0.82)
2High density lipoprotein-cholesterol (mmol/L) 243 1.33(0.34)
2Fasting plasma glucose (mmol/L) 234 5.32(1.38)
Haemoglobin A1c (%) 217 5.25(0.82)
2Metabolic syndrome marker count 234 2.4(1.1)
Vitamin D 3 nmol/L*   
   Total 243 62.2(22.7)
   Women 200 62.4(21.9)
   Men 43 61.7(26.3)
   Skin pigment, light 206 64.8(22.0)
   Skin pigment, variable 37 47.5(20.0)
   Summer 141 68.7(21.9)
   Winter 102 53.3(20.6)
   2Metabolic syndrome, no 135 61.4(22.8)
   2Metabolic syndrome, yes 99 63.8(22.4)
   Non-type II diabetes mellitus 223 62.7(22.7)
   Type II diabetes mellitus 11 55.5(20.1)
  1. * Raw data in pair sets. See text for multivariable regression results. 1Although anthropometry was collected on all 250 participants, data is only shown for 243, as evaluable serum samples for vitamin D3 analysis were available for this number (N) only. 6 samples were not obtained due to unsuccessful venepuncture and 1 sample was lost in transit to the laboratory. For the sub-groups some samples were not evaluable due to sample quality or loss. Sample number (N) is shown for each category. 2 Metabolic syndrome (N=234) is defined by the International Diabetes Federation as 1) Waist circumference: Europids and Undefined groups [such as Maori and Pacific Peoples] ≥ 94 cm (men), ≥ 80 cm (women), Asian (based on a Chinese, Malay and Indian Asian population) ≥ 90 cm (men) and ≥ 80 cm (women). Waist must be included, plus two or more of 2) Systolic and diastolic blood pressure ≥ 130/85 mmHg, 3) High density lipoprotein – cholesterol <1.03 mmol/L (<40 mg/dL) men, <1.29 mmol/L (<50 mg/dL) women 4) Triglyceride ≥ 1.69 mmol/L (150 mg/dL) 5) Fasting plasma glucose ≥ 5.6 mmol/L (≥ 100 mg/dL) and/or on treatment medication for the latter 4 conditions.